Austin, Texas, USA — May 22, 2026
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center has announced the return of its internationally recognized electrophysiology symposium, EPLive 2026, bringing together some of the world’s leading cardiac rhythm specialists to discuss the latest advances in the treatment of complex cardiac arrhythmias. Scheduled for May 28 and 29, the intensive two-day educational conference will focus on emerging electrophysiology technologies, live procedural demonstrations, and advanced treatment strategies designed to improve outcomes for patients living with abnormal heart rhythms.
The event marks the eighth international symposium hosted by TCAI since EPLive was first launched in 2012. Physicians, advanced practice registered nurses, and allied healthcare professionals from around the world are expected to attend the educational meeting, which has become one of the most recognized forums for advanced cardiac electrophysiology training and collaboration. Organizers stated that live procedural cases transmitted directly from TCAI’s advanced Electrophysiology Center will serve as the primary teaching tool, allowing participants to observe real-time clinical decision-making and next-generation treatment approaches.
EPLive 2026 Highlights Next-Generation Arrhythmia Care
One of the major themes of EPLive 2026 will be the growing integration of atrial fibrillation (AFib) ablation and left atrial appendage occlusion (LAAO) into a single combined procedure for patients with elevated stroke risk. Experts believe the streamlined strategy may significantly improve procedural efficiency while reducing complications associated with multiple interventions. By simultaneously treating abnormal heart rhythms and addressing one of the primary sources of stroke risk, physicians aim to improve both clinical outcomes and long-term patient safety.
Conference organizers explained that the combined treatment approach reflects the continuing evolution of minimally invasive cardiac electrophysiology and the increasing use of advanced technologies to personalize arrhythmia management. EPLive 2026 will include live and recorded procedures involving atrial fibrillation ablation, ventricular tachycardia (VT) ablation, left atrial appendage closure technologies, and next-generation electrophysiology devices. The symposium will also feature case presentations from internationally recognized cardiovascular centers across the United States, Canada, Belgium, Colombia, and Italy, including Cleveland Clinic, Houston Methodist, UCLA Health, Massachusetts General Hospital, University of Pennsylvania, and Vancouver General Hospital.
Advertisement
Dr. Andrea Natale, executive medical director of TCAI and course director for EPLive, stated that the conference represents a unique opportunity for the global electrophysiology community to engage in real-time, case-based learning designed to improve patient outcomes worldwide. He emphasized that the symposium combines innovative procedures with expert discussion to create a highly practical educational experience for physicians and healthcare professionals.
Conference Focuses on Safety and Clinical Innovation
EPLive 2026 will place strong emphasis on improving procedural safety, reducing complications, and optimizing the integration of emerging technologies into clinical practice. Educational sessions will focus on updated evidence, advanced treatment guidelines, and practical strategies for improving outcomes during complex cardiac arrhythmia procedures. Experts participating in the symposium will also discuss methods for improving patient safety during cardiac device implantation procedures and lead extraction interventions.
Several internationally recognized TCAI electrophysiologists will participate in the conference, including Dr. Amin Al-Ahmad, Dr. Luigi DiBiase, Dr. Dhanunjaya “DJ” Lakkireddy, Dr. Rodney Horton, Dr. Patrick Hranitzky, and Dr. Jason Zagrodzky. Physicians attending the conference will also be eligible to receive up to 14.5 AMA PRA Category 1 Credit™ hours as part of continuing medical education activities during the symposium.
TCAI Strengthens Leadership in Electrophysiology
The Texas Cardiac Arrhythmia Institute remains one of the most advanced electrophysiology centers in North America. Its 72,000-square-foot facility, opened in 2019, includes six advanced electrophysiology laboratories equipped with robotic systems and minimally invasive technologies designed for the treatment of complex heart rhythm disorders.
Healthcare experts believe the rapid evolution of robotic electrophysiology, advanced imaging systems, and next-generation ablation technologies may significantly reshape the future of cardiac rhythm management worldwide. As cardiovascular disease continues to remain one of the leading causes of mortality globally, conferences such as EPLive are expected to accelerate physician education, innovation adoption, and collaborative research across the international electrophysiology community.
Industry observers also note that increasing demand for minimally invasive cardiovascular procedures reflects broader healthcare trends favoring safer, more precise, and highly personalized treatment solutions capable of improving long-term patient outcomes worldwide.
Source: Texas Cardiac Arrhythmia Institute press release
